Cargando…
The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair
Acute kidney injury (AKI) is one of the most common post-operative complications and is closely associated with increased mortality after open and endovascular thoracoabdominal aortic aneurysm (TAAA) repair. Ribonuclease (RNase) 1 belongs to the group of antimicrobial peptides elevated in septic pat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602227/ https://www.ncbi.nlm.nih.gov/pubmed/33066382 http://dx.doi.org/10.3390/jcm9103292 |
_version_ | 1783603629263945728 |
---|---|
author | Zechendorf, Elisabeth Gombert, Alexander Bülow, Tanja Frank, Nadine Beckers, Christian Peine, Arne Kotelis, Drosos Jacobs, Michael J. Marx, Gernot Martin, Lukas |
author_facet | Zechendorf, Elisabeth Gombert, Alexander Bülow, Tanja Frank, Nadine Beckers, Christian Peine, Arne Kotelis, Drosos Jacobs, Michael J. Marx, Gernot Martin, Lukas |
author_sort | Zechendorf, Elisabeth |
collection | PubMed |
description | Acute kidney injury (AKI) is one of the most common post-operative complications and is closely associated with increased mortality after open and endovascular thoracoabdominal aortic aneurysm (TAAA) repair. Ribonuclease (RNase) 1 belongs to the group of antimicrobial peptides elevated in septic patients and indicates the prediction of two or more organ failures. The role of RNase 1 and its antagonist RNase inhibitor 1 (RNH1) after TAAA repair is unknown. In this study, we analyzed RNase 1 and RNH1 serum levels in patients undergoing open (n = 14) or endovascular (n = 19) TAAA repair to determine their association with post-operative AKI and in-hospital mortality. Increased RNH1 serum levels after open TAAA repair as compared with endovascular TAAA repair immediately after surgery and 12, 48, and 72 h after surgery (all p < 0.05) were observed. Additionally, elevated RNase 1 and RNH1 serum levels 12, 24, and 48 h after surgery were shown to be significantly associated with AKI (all p < 0.05). RNH1 serum levels before and RNase 1 serum levels 12 h after TAAA repair were significantly correlated with in-hospital mortality (both p < 0.05). On the basis of these findings, RNase 1 and RNH1 may be therapeutically relevant and may represent biomarkers for post-operative AKI and in-hospital mortality. |
format | Online Article Text |
id | pubmed-7602227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76022272020-11-01 The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair Zechendorf, Elisabeth Gombert, Alexander Bülow, Tanja Frank, Nadine Beckers, Christian Peine, Arne Kotelis, Drosos Jacobs, Michael J. Marx, Gernot Martin, Lukas J Clin Med Article Acute kidney injury (AKI) is one of the most common post-operative complications and is closely associated with increased mortality after open and endovascular thoracoabdominal aortic aneurysm (TAAA) repair. Ribonuclease (RNase) 1 belongs to the group of antimicrobial peptides elevated in septic patients and indicates the prediction of two or more organ failures. The role of RNase 1 and its antagonist RNase inhibitor 1 (RNH1) after TAAA repair is unknown. In this study, we analyzed RNase 1 and RNH1 serum levels in patients undergoing open (n = 14) or endovascular (n = 19) TAAA repair to determine their association with post-operative AKI and in-hospital mortality. Increased RNH1 serum levels after open TAAA repair as compared with endovascular TAAA repair immediately after surgery and 12, 48, and 72 h after surgery (all p < 0.05) were observed. Additionally, elevated RNase 1 and RNH1 serum levels 12, 24, and 48 h after surgery were shown to be significantly associated with AKI (all p < 0.05). RNH1 serum levels before and RNase 1 serum levels 12 h after TAAA repair were significantly correlated with in-hospital mortality (both p < 0.05). On the basis of these findings, RNase 1 and RNH1 may be therapeutically relevant and may represent biomarkers for post-operative AKI and in-hospital mortality. MDPI 2020-10-14 /pmc/articles/PMC7602227/ /pubmed/33066382 http://dx.doi.org/10.3390/jcm9103292 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zechendorf, Elisabeth Gombert, Alexander Bülow, Tanja Frank, Nadine Beckers, Christian Peine, Arne Kotelis, Drosos Jacobs, Michael J. Marx, Gernot Martin, Lukas The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair |
title | The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair |
title_full | The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair |
title_fullStr | The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair |
title_full_unstemmed | The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair |
title_short | The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair |
title_sort | role of ribonuclease 1 and ribonuclease inhibitor 1 in acute kidney injury after open and endovascular thoracoabdominal aortic aneurysm repair |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602227/ https://www.ncbi.nlm.nih.gov/pubmed/33066382 http://dx.doi.org/10.3390/jcm9103292 |
work_keys_str_mv | AT zechendorfelisabeth theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT gombertalexander theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT bulowtanja theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT franknadine theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT beckerschristian theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT peinearne theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT kotelisdrosos theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT jacobsmichaelj theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT marxgernot theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT martinlukas theroleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT zechendorfelisabeth roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT gombertalexander roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT bulowtanja roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT franknadine roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT beckerschristian roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT peinearne roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT kotelisdrosos roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT jacobsmichaelj roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT marxgernot roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair AT martinlukas roleofribonuclease1andribonucleaseinhibitor1inacutekidneyinjuryafteropenandendovascularthoracoabdominalaorticaneurysmrepair |